Transceptar Technologies
Kefar Sava, Israel
Transceptar Technologies has developed an algorithm capable of interpreting DNA data and producing highly effective reports for physicians and healthcare professionals. The company's algorithm, called TRCPR-18, compares and processes more than 40 million genetic markers from each person and is used internationally, including through its FullDNA brand. FullDNA has offices in Brazil and Portugal, and more than 2,000 practitioners have prescribed its tests and solutions over the past decade. FullDNA is accelerated by the FIEP (Parana State Industries Federation) in Brazil. Using a proprietary artificial intelligence mechanism, the company's algorithms explore more than 8,700 genes and obtain a detailed result of the genetic predispositions of each individual, focusing on health, nutrition, physical fitness, and skin. Transceptar has developed more than 36 algorithms since 2010.
Company Info
- Founded
- 2019
- Website
- transceptar.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Transceptar Technologies?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.